ATE233724T1 - Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel - Google Patents

Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel

Info

Publication number
ATE233724T1
ATE233724T1 AT98936726T AT98936726T ATE233724T1 AT E233724 T1 ATE233724 T1 AT E233724T1 AT 98936726 T AT98936726 T AT 98936726T AT 98936726 T AT98936726 T AT 98936726T AT E233724 T1 ATE233724 T1 AT E233724T1
Authority
AT
Austria
Prior art keywords
chain alcohol
long chain
products containing
containing same
medicinal products
Prior art date
Application number
AT98936726T
Other languages
German (de)
English (en)
Inventor
Bang Luu
Gaby Schmitt
Florence Keyling
Celine Girlanda
Masashi Yamada
Yukie Suma
Original Assignee
Meiji Milk Prod Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Prod Co Ltd filed Critical Meiji Milk Prod Co Ltd
Application granted granted Critical
Publication of ATE233724T1 publication Critical patent/ATE233724T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C07C45/676Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98936726T 1997-08-13 1998-08-11 Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel ATE233724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21847497 1997-08-13
PCT/JP1998/003560 WO1999008987A1 (en) 1997-08-13 1998-08-11 Cyclohexenone long-chain alcohol and medicament containing same

Publications (1)

Publication Number Publication Date
ATE233724T1 true ATE233724T1 (de) 2003-03-15

Family

ID=16720502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936726T ATE233724T1 (de) 1997-08-13 1998-08-11 Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel

Country Status (7)

Country Link
US (1) US6228893B1 (enExample)
EP (1) EP1003706B1 (enExample)
JP (1) JP3766591B2 (enExample)
AT (1) ATE233724T1 (enExample)
CA (1) CA2299308C (enExample)
DE (1) DE69811905T2 (enExample)
WO (1) WO1999008987A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4469441B2 (ja) 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
JP4490536B2 (ja) * 2000-01-31 2010-06-30 明治乳業株式会社 脳血管障害に基づく疾患の予防又は治療薬
JP2002068973A (ja) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd 幹細胞分化誘導促進剤
US20040115810A1 (en) * 2000-10-04 2004-06-17 Bang Luu Stem cell differentiation-inducing promoter
JP4250882B2 (ja) * 2000-10-18 2009-04-08 住友化学株式会社 スルホン誘導体およびその製造方法
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
JP3836684B2 (ja) * 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
WO2002094252A1 (en) * 2001-05-24 2002-11-28 Meiji Dairies Corporation Preventive or remedy for diseases caused by cerebrovascular disturbances
JP2005518403A (ja) * 2002-01-09 2005-06-23 トリデント サイエンシーズ エルエルシー アンドロゲンレセプターをブロックする化合物
JP4035332B2 (ja) * 2002-01-22 2008-01-23 明治乳業株式会社 シクロヘキセノン長鎖アルコールの製造法
US7307098B2 (en) 2002-07-19 2007-12-11 Meiji Dairies Corporation Indole derivatives and drugs containing the same
CA2519178C (en) 2003-03-28 2010-01-12 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
CA2583699C (en) * 2004-10-13 2012-11-20 Meiji Dairies Corporation Stat3 phosphorylation inhibitor and notch1 expression inhibitor
CN101180041B (zh) * 2005-01-18 2011-04-13 明治乳业株式会社 感觉障碍治疗剂
EP1854777A4 (en) * 2005-02-28 2010-07-07 Meiji Dairies Corp LONG-CHAINED HYDROCHINONE DERIVATIVE AND / OR LONG-CHAINED PHENOXY DERIVATIVE AND PHARMACEUTICAL PREPARATION CONTAINING THEREOF
US20080312336A1 (en) * 2005-05-26 2008-12-18 Keisuke Satoh Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder
WO2013147072A1 (ja) * 2012-03-29 2013-10-03 大鵬薬品工業株式会社 3-(15-ヒドロキシペンタデシル)-2,4,4-トリメチル-2-シクロヘキセン-1-オンの共結晶
JP5566521B1 (ja) 2013-09-27 2014-08-06 大鵬薬品工業株式会社 膀胱・尿道協調不全改善剤
US20170035705A1 (en) * 2015-08-04 2017-02-09 Taiho Pharmaceutical Co., Ltd. Detrusor hyperactivity with impaired contractility ameliorating agent
BR112018014841B1 (pt) 2016-01-22 2022-03-03 Taiho Pharmaceutical Co., Ltd. Álcoois de cadeia longa cicloexenona, seus usos e métodos para a produção dos mesmos com alta pureza
JP2022013721A (ja) 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤
US20230295068A1 (en) * 2020-08-07 2023-09-21 Taiho Pharmaceutical Co., Ltd. Novel cycloalkenone compound or salt thereof
US20250178998A1 (en) 2022-02-09 2025-06-05 Taiho Pharmaceutical Co., Ltd. Crystal form of cyclohexenone compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448697B1 (fr) * 1989-10-13 1996-04-10 Neurofit Analogues de la vitamine a, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
ATE105282T1 (de) * 1992-11-18 1994-05-15 Medafor Langkettige fettalkohole mit neurotropischer und gedaechtnissfoerdernder wirkung.

Also Published As

Publication number Publication date
JP3766591B2 (ja) 2006-04-12
DE69811905T2 (de) 2003-11-06
WO1999008987A1 (en) 1999-02-25
EP1003706A1 (en) 2000-05-31
DE69811905D1 (de) 2003-04-10
CA2299308C (en) 2008-03-25
US6228893B1 (en) 2001-05-08
JP2001515058A (ja) 2001-09-18
EP1003706B1 (en) 2003-03-05
CA2299308A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
ATE233724T1 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
EP1213296A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND INTERMEDIATE PRODUCTS OBTAINED DURING THEIR PRODUCTION
MA25035A1 (fr) Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
WO1993014767A3 (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
ATE270884T1 (de) Langkettiger cyclohexenonalkohol zur behandlung von amyotropher lateraler sklerose
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
ATE437636T1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
DE69715208D1 (de) Anti-helicobacter pylori zusammensetzungen die 1-methylcarbapenem-derivate als wirkstoffe enthalten
HUP9601680A2 (hu) Benzizotiazolil-szubsztituált amino-metil-krománok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és a vegyületek alkalmazása
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
DE69320367D1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
ATE492274T1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
FR2700165B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
DE69625226D1 (de) Neue n-acetylierte 4-hydroxyphenylaminen derivate mit analgetischen eigenschaften sowie diese enthaltende arzneimittel
FR2721314B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
CA2348319A1 (en) Cyclohexenol derivative and medicament containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties